Latest Breaking News On - Prematurity risk assessment combined - Page 1 : comparemela.com

Sera Prognostics Inc Announces Preliminary Efficacy Met in Pivotal Prime Study Interim Look - Enrollment to Stop Due to Success

Sera Prognostics Inc. announced that the Data Safety Monitoring Board overseeing its pivotal Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs study.

United statesSera prognostics incSera prognosticsData safety monitoring boardPrematurity risk assessment combinedClinical interventionsImproved neonatalDimes report card

Sera Prognostics (SERA) Announces Primary Endpoint Criteria Met In Pivotal Prime Study Interim Look

Sera Prognostics (SERA) Announces Primary Endpoint Criteria Met In Pivotal Prime Study Interim Look
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Zhenya lindgardtSera prognostics incPregnancy companyData safety monitoring boardPrematurity risk assessment combinedClinical interventionsImproved neonatal

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK

SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK
kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityZhenya lindgardtPregnancy companySera prognostics incExchange commission onPrnewswire sera prognostics incPrognostics incData safety monitoring boardPrematurity risk assessment combinedClinical interventionsImproved neonatalSera prognosticsDimes report cardPrivate securities litigation reform actFinal prospectus

Sera Prognostics Shares More Than Double on Study Efficacy

By Denny Jacob Sera Prognostics shares more than doubled following news of study efficacy being met. The stock surged to $5.24 in early trading, vs..

Denny jacobData safety monitoring boardPrematurity risk assessment combinedClinical interventionsImproved neonatal outcomesArticle normalBiotechnology servicesHealthcare life sciencesSera prognosticsLife sciences